Search clinical trials for: Tirofiban

Total 58 results

Beijing Tiantan Hospital

Not yet recruiting

Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）

TIA | Ischemic Stroke, Acute | Symptomatic Intracranial Artery Stenosis

China
Medicure
SCRI Development Innovations, LLC

Completed

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention (SAVI-PCI)

Myocardial Infarction | Unstable Angina | Acute Coronary Syndromes

United States
The First Hospital of Jilin University

Not yet recruiting

Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke

Acute Ischemic Stroke
Hospices Civils de Lyon

Completed

GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction (AGIR2)

Acute Myocardial Infarction

France
Beijing Anzhen Hospital

Unknown

Impacts of Superselective Infarct-related Artery (IRA) Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in Acute Myocardial Infarction (AMI) Patients (SUIT-AMI)

Myocardial Infarction

China
Kosuyolu Heart Hospital
The Society of Cardiac Health Protection

Completed

Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients

Acute Myocardial Infarction
University of Iowa

Withdrawn

Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke (iTREMT)

Ischemic Stroke | Acute Ischemic Stroke

United States
Shanghai East Hospital
Jinan Central Hospital; Ningbo No. 1 Hospital; Shanghai 6th People's Hospital; Shanghai... and other collaborators

Completed

One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China (OPTIMISTIC)

Ischemic Stroke

China
Second Hospital of Jilin University

Unknown

Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease

Coronary Artery Disease

China
Hospital Avicenne

Terminated

Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation (SISCA)

CORONARY DISEASE

France
The First Affiliated Hospital of University of...

Not yet recruiting

Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT) (ASSET-IT)

Acute Ischemic Stroke

China
Medicure
SCRI Development Innovations, LLC

Withdrawn

Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention (ATLAST-PCI)

Myocardial Infarction | Percutaneous Coronary Intervention | Unstable Angina | Acute Coronary Syndromes
Zhongming Qiu
The Second Affiliated Hospital of Chongqing Medical University; Mianyang Central... and other collaborators

Not yet recruiting

Tirofiban for Successful Endovascular Stroke Thrombectomy (ADJUVANT-2)

Stroke, Acute Ischemic
Capital Medical University

Recruiting

Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke (TREND)

Acute Stroke

China
Samsung Medical Center

Completed

The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction

Acute Myocardial Infarction
University of Bologna

Completed

FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab (FATA)

Acute Myocardial Infarction

Italy
Xinqiao Hospital of Chongqing
Zhejiang University

Recruiting

Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke (ADJUVANT)

Stroke, Acute Ischemic

China
David Hasan

Completed

Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)

Subarachnoid Hemorrhage, Aneurysmal

United States
Shanghai Jiao Tong University School of Medicine

Completed

Tirofiban in Stenting for Long Coronary Lesion (PETITION)

Coronary Artery Disease

China
Second Affiliated Hospital of Guangxi Medical University
CSPC Pharmaceutical Group Limited

Not yet recruiting

Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke (ATTIS)

Acute Ischemic Stroke
Shenyang Northern Hospital

Completed

BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial. (BRIGHT)

Percutaneous Coronary Intervention | Acute Myocardial Infarction

China
GrandPharma (China) Co., Ltd.

Active, not recruiting

A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke (RESET)

Acute Ischemic Stroke

China
Beijing Tiantan Hospital
GrandPharma (China) Co., Ltd.

Recruiting

Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction (STRATEGY)

Branch Atheromatous Disease

China
Assiut University

Unknown

Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome (TISP)

High Bolus Dose of Tirofiban
S. Anna Hospital

Completed

Safety of High-dose Tirofiban During Coronary Angioplasty (SANTISS)

Coronary Artery Disease

Italy
Centre Hospitalier Sud Francilien

Completed

Tirofiban Plus Intravenous Thrombolysis in Acute Anterior Choroidal Infarction or Paramedian Pontine Infarction (TITACIPPI)

Acute Anterior Choroidal Infarction (ACI) | Paramedian Pontine Infarction (IPP)

France
The Baruch Padeh Medical Center, Poriya

Unknown

Treating Acute MI Patients With Aggrastat on Their Way to Hospital

Acute Myocardial Infarction

Israel
The First Affiliated Hospital of Zhengzhou University
The First Affiliated Hospital of Henan University of Science and Technology; First Affiliated Hospital of Xinjiang Medical University and other collaborators

Unknown

Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI (NOSLOWFLOW-Ⅰ)

ST Segment Elevation Myocardial Infarction | Primary Percutaneous Coronary Intervention

China
Seoul National University Bundang Hospital

Completed

Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients

Non-ST Elevation Myocardial Infarction
Xijing Hospital

Unknown

Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty

ST-elevation Myocardial Infarction

China
Lu Hua

Recruiting

Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban

Intracranial Aneurysm

China
Medicure

Completed

Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function

Renal Insufficiency

United States
The First Affiliated Hospital of Zhengzhou University
The First Affiliated Hospital of Henan University of Science and Technology; First Affiliated Hospital of Xinjiang Medical University and other collaborators

Unknown

Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI (NOSLOWFLOW-Ⅱ)

ST Segment Elevation Myocardial Infarction | Elective Percutaneous Coronary Intervention

China
Shanghai Zhongshan Hospital

Unknown

Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.

ST Elevation Myocardial Infarction

China
Jordan Hospital
Merck Sharp & Dohme LLC

Unknown

The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention

Coronary Artery Disease

Jordan
Xijing Hospital

Unknown

Cocktail Injection Improves Outcomes of FFR Guided PCI (CocktailII)

Acute Coronary Syndromes

China
Capital Medical University

Terminated

Tirofiban for Patients Treated With Alteplase (MR TEA)

Ischemic Stroke

China
The First Affiliated Hospital with Nanjing Medical...
National Natural Science Foundation of China

Unknown

Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients (DPABIAP)

Coronary Artery Disease

China
Università degli Studi di Ferrara

Completed

Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse (FABOLUS PRO)

ST Segment Elevation Myocardial Infarction

Italy
TC Erciyes University

Completed

Intracoronary Tirofiban on No-Reflow Phenomena

No-Reflow Phenomenon

Turkey
Marco Valgimigli

Unknown

Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI

Myocardial Infarction

Italy
Xiang Luo
Wuhan University; Beijing Tiantan Hospital; The Affiliated Nanjing Drum Tower... and other collaborators

Not yet recruiting

Tirofiban After Successful MT Recanalization in AIS (ATTRACTION)

Acute Ischemic Stroke | Vessel Occlusion
Tianjin Huanhu Hospital

Recruiting

Endovascular Treatment of Acute Ischemic Stroke With Underlying Intracranial Artery Stenosis

Acute Ischemic Stroke | Large Vessel Occlusion | Intracranial Artery Occlusion With Cerebral Infarction | Endovascular Treatments

China
Peking Union Medical College Hospital
Pharmaron (Chengdu) Clinical Services Co., Ltd.

Recruiting

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT) (BRANT)

Branch Atheromatous Disease

China
Shanghai Jiao Tong University School of Medicine
Changhai Hospital; Ministry of Science and Technology of the People´s Republic...

Terminated

Shanghai Registry of Acute Coronary Events

Coronary Artery Disease | Acute Coronary Syndrome

China
Fudan University

Completed

Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction (ERUPTION)

Myocardial Infarction | Percutaneous Coronary Intervention | Thrombolytic Therapy

China
The Prince Charles Hospital
Sanofi; Merck Sharp & Dohme LLC

Completed

Tirofiban and Enoxaparin in High Risk Coronary Intervention

Acute Coronary Syndrome

Australia
University of Milan
Fondazione "Un Cuore per Milano" - a no profit foundation

Completed

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 (PIC-19)

Pneumonia, Viral | Embolism and Thrombosis | Respiratory Failure | Corona Virus Infection

Italy
Inova Health Care Services

Terminated

Antiplatelet Effects of Tirofiban vs. Cangrelor N-STEMI Patients Undergoing Percutaneous Coronary Intervention

Non-ST Elevation Myocardial Infarction (NSTEMI)

United States
Pusan National University Yangsan Hospital
AstraZeneca

Unknown

Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome (TE-CLOT)

Non-ST Segment Elevation Acute Coronary Syndrome

Korea, Republic of

Search clinical trials for: Tirofiban

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations